期刊文献+

Impact of Combination Use of 0.004% Travoprost and 2% Pilocarpine on Matrix Metalloproteinases Synthesized by Rabbit Ciliary Muscle:a Pilot Study

Impact of Combination Use of 0.004% Travoprost and 2% Pilocarpine on Matrix Metalloproteinases Synthesized by Rabbit Ciliary Muscle:a Pilot Study
下载PDF
导出
摘要 Objective To explore the impact of combination use of prostaglandin analogue and cholinergic agonists on main matrix metalloproteinases(MMPs)synthesized by albino rabbit ciliary muscle.Methods Normal adult albino rabbits were divided into the control group,2%pilocarpine group,0.004%travoprost group and travoprost plus pilocarpine group.Two rabbits in the control group were executed after treated with normal saline for one day.Two rabbits were separately executed on the 7th,14th and 24th day of the treatment in each drug treated group.In each subgroup ciliary muscle band of 4 eyes was taken and made into homogenate.The MMPs activities of 10 subgroups were assayed by zymography.Bands’intensity which represents the activity of MMPs was measured by the UltraViolet Illumination system.Results A bright band of MMP-1/2 was showed on each lane at the position corresponding to the molecular weight of 62 kD in the ciliary smooth muscles electrophoresis.When ion Zn and Ca was displaced by MMPs inhibitor EDTA,this bright band disappeared.Compared with the control group,MMP1/2 activity increased by 4.0%,4.1%and 14.0%after 7,14 and 24 days of pilocarpine treatment.Corresponding data was23.2%,61.7%and 111.5%in the travoprost group and 49.3%,68.0%and 88.4%in the travoprost plus pilocarpine group.Conclusions Pilocarpine has little effect on activity of MMP1/2.Travoprost can increase activity of MMP1/2 gradually.Activity of MMP1/2 is rapidly increased by pilocarpine combined with travoprost,but shows small change with the prolonged treatment.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2013年第4期229-232,共4页 中国医学科学杂志(英文版)
关键词 matrix metalloproteinases prostaglandin analogue PILOCARPINE 基质金属蛋白酶抑制剂 毛果芸香碱 睫状肌 组合使用 白兔 合成 药物治疗 MMPs
  • 相关文献

参考文献1

二级参考文献13

  • 1李欣,赵家良.0.03%Bimatoprost对正常无色素兔的降眼压作用及安全性研究[J].眼科研究,2007,25(4):288-291. 被引量:2
  • 2Wu LL,Huang P, Gao YX, et al. A 12-week, double-masked, parallel- group study of the safety and efficacy of travoprost O. 004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma[J]. J Glaucoma,2011,20:388-391.
  • 3Toris CB, Camras CB, Yablonski ME, et al. Effects of exogenous prostaglandins on aqueous humor dynatics and blood-aqueous barrierfunction[J]. Surv Ophthalmol, 1997,41 ( suppl 2 ) :S69-S75.
  • 4Nilsson SFE,Samublsson M, Bill A,et al. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-l-isopropylester in the cynomolgus monkey [ J ]. Exp Eye Res, 1989,48 : 707-716.
  • 5Yousufzai SY, Zheng P, Abdel-Latif AA. Musearinic stimulation of arachidonic acid release and prostaglandin synthesis in bovine ciliary muscle: prostaglandins induce cyclic AMP formation and muscle relaxation[J]. Exp Eye Res, 1994,58 : 513-522.
  • 6Toor A, Chanis RA, Polik off LA, et al. Additivity of pilocarpine to bimatoprost in ocular hypertension and early glaucoma[ J ]. J Glaucoma, 2005,14 : 243 -248.
  • 7Kent AR, Vroman DT,Thomas TJ, et al. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension[J]. J Glaucoma, 1999,8 : 257-262.
  • 8Diestelhorst M. The additive intraocular pressure-lowering effect of latanoprost 0. 005% daily once and pilocarpine 2% t. i. d. in patients with open-angle glaucoma or ocular hypertension, a 6-month,randomized, muhicenter study. German Latanoprost Study Group[ J]. Graefe' s Arch Clin Exp Ophthalmol,2000,238 : 433-439.
  • 9Sarchahi AA,Abbasi N, Gholipour MA. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs[J]. Vet Ophthalmo1,2012,15 ( Suppl 1 ) :S64-S70.
  • 10Hoyng PF, Rulo A, Greve E, et al. The additive intraocular pressure- lowering effect of latanoprost in combined therapy with other ocular hypotensive agents [ J ]. Surv Ophthalmol, 1997,41( Suppl 2 ) :S93-S98.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部